Herbal Drugs Used in the Management of Alzheimer’s Disease: A Comprehensive Review of Phyto-Therapeutic Approaches, Mechanisms and Future Perspectives
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia, characterized by progressive impairment of memory, cognition, behavior and activities of daily living. Its pathogenesis is multifactorial and involves amyloid-β (Aβ) aggregation, hyperphosphorylation of tau protein, cholinergic dysfunction, oxidative stress, mitochondrial impairment, neuroinflammation, synaptic dysfunction and neuronal loss.¹–⁴ Although conventional pharmacotherapy includes acetylcholinesterase inhibitors, memantine and, more recently, disease-modifying anti-amyloid antibodies, limitations such as modest symptomatic efficacy, adverse effects, treatment burden, cost and the need for careful patient selection continue to stimulate research into complementary therapeutic approaches.⁵–⁷ Medicinal plants contain diverse bioactive compounds capable of acting simultaneously on several pathological pathways. Important herbal candidates investigated in AD include Ginkgo biloba, Bacopa monnieri, Withania somnifera, Curcuma longa, Crocus sativus, Salvia officinalis, Melissa officinalis, Panax ginseng, Centella asiatica, Huperzia serrata, Nigella sativa and Camellia sinensis.⁸–¹² Their reported activities include acetylcholinesterase inhibition, antioxidant and anti-inflammatory effects, modulation of amyloid and tau pathology, mitochondrial protection, enhancement of neurotrophic signaling and improvement of synaptic plasticity. Recent systematic reviews of human studies suggest that Ginkgo biloba, Crocus sativus, Salvia officinalis and Melissa officinalis have produced encouraging cognitive or behavioral findings, although study quality, formulations, doses and treatment duration vary substantially.¹³,¹⁴ Future development should focus on standardized phytopharmaceutical preparations, pharmacokinetic optimization, advanced drug-delivery systems, validated biomarkers, well-designed randomized clinical trials and rational combination therapy. Herbal medicines therefore represent a promising research avenue, but current evidence does not justify considering them universally equivalent or superior to established pharmacological treatment. Keywords: Alzheimer’s disease; herbal drugs; curcumin; Ginkgo biloba; amyloid-β; tau; cognitive impairment.
Authors
- Girish Kumar Yadav
- Rambabu Sharma
- Amarjeet Singh
Publication Details
- Journal
- Journal of Drug Delivery and Therapeutics
- Published
- 2026-11-15
- DOI
- https://doi.org/10.22270/jddt.v16i11.8067
- Primary Topic
- Medicinal Plants and Neuroprotection
- Type
- article
- Field-Weighted Citation Impact
- 0.00